Arsenal Medical


Arsenal Medical is dedicated to transforming medical devices with innovative biomaterials. Founded by Carmichael Roberts, Robert Langer, and George Whitesides, the company aims to address unmet medical needs through thoughtfully designed products. Their vision is to provide local therapy for important medical conditions across various therapeutic areas, leveraging expertise in materials science and chemistry.

Arsenal Medical

Arsenal Medical


What We Do

A rapidly expanding, hydrophobic foam designed for life-threatening trauma. It is intended to control hemorrhage in the abdomen, providing patients time to reach surgery. Recognized as a breakthrough device by the FDA.

An injectable, shear-responsive material that enables deep neurovascular occlusion. It is used for conditions like chronic subdural hematomas and hypervascular tumors, providing complete vascular occlusion.


FDA Regulated Medical Devices


Key People

President & CEO

Chief Financial Officer

Chief Operating Officer

Executive Vice President, Clinical and Regulatory

Vice President, Quality

Vice President, Human Resources


News & Updates

First patient enrolled in trial to evaluate safety and feasibility of innovative embolic agent in expanded patient population utilizing middle meningeal artery embolization (MMAe).

Data show NeoCast™ met primary endpoints and enabled significant distal penetration of hypervascular brain tumors.

NeoCast occluded approximately five times more vessel branches compared to the market-leading liquid embolic agent in swine kidneys.